OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

Regulatory Filings • Apr 3, 2024

National Storage Mechanism | Additional information

RNS Number : 0207J

Oxford Cannabinoid Tech.Holdings

03 April 2024

OCT Company Update with Doceo

Oxford Cannabinoid Technologies Holdings plc (LSE:OCTP), a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative cannabinoid medicines, is pleased to share the following Company Update video with Doceo.

Clarissa Sowemimo-Coker, Chief Executive Officer, discusses the significant unmet need for non-addictive treatments to help people living with debilitating conditions in a global pain market that is estimated to be worth £75bn by 2027.

[Video content removed for conversion]

For further information on Doceo please visit  www.doceo.tv  or contact the team on  info@doceo.tv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAZZGGDDZFGDZM